HomeCompareDACHF vs CHD

DACHF vs CHD: Dividend Comparison 2026

DACHF yields 4.16% · CHD yields 1.28%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DACHF wins by $11.67M in total portfolio value
10 years
DACHF
DACHF
● Live price
4.16%
Share price
$8.44
Annual div
$0.35
5Y div CAGR
71.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$11.70M
Annual income
$9,653,176.75
Full DACHF calculator →
CHD
CHD
● Live price
1.28%
Share price
$93.32
Annual div
$1.19
5Y div CAGR
23.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.4K
Annual income
$1,302.64
Full CHD calculator →

Portfolio growth — DACHF vs CHD

📍 DACHF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodDACHFCHD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, DACHF + CHD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
DACHF pays
CHD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DACHF
Annual income on $10K today (after 15% tax)
$353.96/yr
After 10yr DRIP, annual income (after tax)
$8,205,200.24/yr
CHD
Annual income on $10K today (after 15% tax)
$108.62/yr
After 10yr DRIP, annual income (after tax)
$1,107.24/yr
At 15% tax rate, DACHF beats the other by $8,204,092.99/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DACHF + CHD for your $10,000?

DACHF: 50%CHD: 50%
100% CHD50/50100% DACHF
Portfolio after 10yr
$5.86M
Annual income
$4,827,239.69/yr
Blended yield
82.32%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CHD right now

DACHF
No analyst data
Altman Z
2.0
Piotroski
5/9
CHD
Analyst Ratings
18
Buy
15
Hold
1
Sell
Consensus: Buy
Price Target
$98.40
+5.4% upside vs current
Range: $82.00 — $110.00
Altman Z
4.9
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DACHF buys
0
CHD buys
0
No recent congressional trades found for DACHF or CHD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricDACHFCHD
Forward yield4.16%1.28%
Annual dividend / share$0.35$1.19
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR71.7%23.1%
Portfolio after 10y$11.70M$26.4K
Annual income after 10y$9,653,176.75$1,302.64
Total dividends collected$11.50M$5.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: DACHF vs CHD ($10,000, DRIP)

YearDACHF PortfolioDACHF Income/yrCHD PortfolioCHD Income/yrGap
1← crossover$11,415$715.00$10,857$157.30+$558.00DACHF
2$13,524$1,309.68$11,814$196.49+$1.7KDACHF
3$16,960$2,489.85$12,887$245.97+$4.1KDACHF
4$23,158$5,010.66$14,097$308.68+$9.1KDACHF
5$35,758$10,978.76$15,473$388.49+$20.3KDACHF
6$65,464$27,202.50$17,046$490.55+$48.4KDACHF
7$149,960$79,913.86$18,861$621.76+$131.1KDACHF
8$454,211$293,754.32$20,973$791.47+$433.2KDACHF
9$1,913,762$1,427,755.53$23,454$1,012.51+$1.89MDACHF
10$11,700,902$9,653,176.75$26,398$1,302.64+$11.67MDACHF

DACHF vs CHD: Complete Analysis 2026

DACHFStock

Daicel Corporation engages in the medical/healthcare, smart, safety, materials, engineering plastics, and other businesses in Japan, China, and internationally. The company offers 1,3-Butylene glycol and polyglycerin for cosmetics; chiral and achiral columns/stationary phases, analytical tools, analytical/purification/synthesis/formulation services, chiral and bio reagents, analytical standards, and DNA and RNA-based probes; triacetylcellulose, high performance film, solvent for electronic materials, polymer for resist, semiconductor process cleaning agent, optical parts and lens unit, silver nanoparticle ink, and organic semiconductor devices; and inflators, pyro-fuse, and safety device for non-mobility products; and acetic acid and derivatives, cellulose acetate, acetate tow, cycloaliphatic epoxies, caprolactone, ketene derivatives, and alkylamines. It also provides ceramide derived from konjac root, equol derived from soybeans, ß-cryptoxanthin derived from citrus unshiu, and lactobionic acid derived from milk; DiSPERZiSTA, a dispersible filler for dietary supplement tablet; and MOiSTCARM, a make granules easy to swallow. In addition, the company offers engineering plastics and plastic compound products, high performance polymer, functional sheets, formed trays, and packaging films; water treatment systems and diffusers, such as UF membrane modules, ultra-fine bubble membrane diffusers, and E mizu showers. Its products are used in transportation, electronics, medical care, personal care, everyday life, and environment and energy applications. The company was formerly known as Daicel Chemical Industries, Ltd. and changed its name to Daicel Corporation in October 2011. Daicel Corporation was incorporated in 1919 and headquartered in Osaka, Japan.

Full DACHF Calculator →

CHDConsumer Staples

Church & Dwight Co., Inc. develops, manufactures, and markets household, personal care, and specialty products. It operates through three segments: Consumer Domestic, Consumer International, and Specialty Products Division. The company offers cat litters, carpet deodorizers, laundry detergents, and baking soda, as well as other baking soda based products under the ARM & HAMMER brand; condoms, lubricants, and vibrators under the TROJAN brand; stain removers, cleaning solutions, laundry detergents, and bleach alternatives under the OXICLEAN brand; battery-operated and manual toothbrushes under the SPINBRUSH brand; home pregnancy and ovulation test kits under the FIRST RESPONSE brand; depilatories under the NAIR brand; oral analgesics under the ORAJEL brand; laundry detergents under the XTRA brand; gummy dietary supplements under the L'IL CRITTERS and VITAFUSION brands; dry shampoos under the BATISTE brand; water flossers and replacement showerheads under the WATERPIK brand; FLAWLESS products; cold shortening and relief products under the ZICAM brand; and oral care products under the THERABREATH brand. Its specialty products include animal productivity products, such as MEGALAC rumen bypass fat, a supplement that enables cows to maintain energy levels during the period of high milk production; BIO-CHLOR and FERMENTEN, which are used to reduce health issues associated with calving, as well as provides needed protein; and CELMANAX refined functional carbohydrate, a yeast-based prebiotic. The company offers sodium bicarbonate; and cleaning and deodorizing products. It sells its consumer products through supermarkets, mass merchandisers, wholesale clubs, drugstores, convenience stores, home stores, dollar and other discount stores, pet and other specialty stores, and websites and other e-commerce channels; and specialty products to industrial customers and livestock producers through distributors. The company was founded in 1846 and is headquartered in Ewing, New Jersey.

Full CHD Calculator →
📬

Get this DACHF vs CHD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DACHF vs SCHDDACHF vs JEPIDACHF vs ODACHF vs KODACHF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.